Table 1.
Targets | Aptamer sequences | Nanomaterials | Sensor type/method | Type of aptamer | Length (nt)a) | Limit of detection (LOD) | References |
---|---|---|---|---|---|---|---|
S. aureus |
I: 5’-TCC CTA CGG CGC TAA CCC CCC CAG TCC GTC CTC CCA GCC TCA CAC CGC CAC CGT GCT ACA AC-3’ II: 5’-TCC CTA CGG CGC TAA CCT CCC AAC CGC TCC ACC CTG CCT CCG CCT CGC CAC CGT GCT ACA AC-3’ |
AuNPs | Aptamer-conjugated GNPs and a resonance light-scattering detection system | DNA | 40 | – | [44] |
I: 5’-TCC CTA CGG CGC TAA CCC CCC CAG TCC GTC CTC CCA GCC TCA CAC CGC CAC CGT GCT ACA ACT TTT TTT TT-3’ II: 5’-TCC CTA CGG CGC TAA CCC CCC CAG TCC GTC CTC CCA GCC TCA CAC CGC CAC CGT GCT ACA ACT TTT TTT T-3’ |
Fe3O4@mTiO2 | Capture platform based on Fe3O4@mTiO2 modified with target aptamer | DNA | 71 | 10–2000 CFU/mL | [45] | |
apt: 5’-GCA ATG GTA CGG TAC TTC CTC GGC ACG TTC TCA GTA GCG CTC GCT GGT CAT CCC ACA GCT ACG TCA AAA GTG CAC GCT ACT TTG CTA A-3’ | – | Vertical capacitance apta-sensors | DNA | 88 |
100 CFU/mL Biofilm: 20% of the area |
[46] | |
apt: 5’-GCA ATG GTA CGG TAC TTC CTC GGC ACG TTC TCA GTA GCG CTC GCT GGT CAT CCC ACA GCT ACG TCA AAA GTG CAC GCT ACT TTG CTA A-3’ | – | Electrical antimicrobial susceptibility test (e-AST) system | DNA | 88 | – | [47] | |
MASA | – | Streptavidin Magnetic Beads | CRISPR-Cas12a assisted RCA | – | – | 102–106 CFU/mL | [32] |
E. coli | apt: 5’-ATC CGT CAC ACC TGC TCT ACT GGC CGG CTC AGC ATG ACT AAG AAG GAA GTT ATG TGG TGT TGG CTC CCG TAT TTT TTT TTT-3’ | Fe3O4@mTiO2 | – | DNA | 81 | [45] | |
apt: 5’-GCA ATG GTA CGG TAC TTC CCC ATG AGT GTT GTG AAA TGT TGG GAC ACT AGG TGG CAT AGA GCC GCA AAA GTG CAC GCT ACT TTG CTA A-3’ | – | Vertical capacitance ap-tasensors | DNA | 88 |
100 CFU/mL Biofilm: 20% of the area |
[46] | |
apt: 5’-GCA ATG GTA CGG TAC TTC CCC ATG AGT GTT GTG AAA TGT TGG GAC ACT AGG TGG CAT AGA GCC GCA AAA GTG CAC GCT ACT TTG CTA A-3’ | – | Electrical antimicrobial susceptibility test (e-AST) system | DNA | 88 | – | [47] | |
Peptidoglycan |
I: 5’-TCG CGC GAG TCG TCT GGG GAC AGG GAG TGC GCT GCT CCC CCC GCA TCG TCC TCC C-3’ II: 5’-TCG CGC GAG TCG TCT GGG GGA CTA GAG GAC TTG TGC GGC CCC GCA TCG TCC TCC C-3’ |
– | – | DNA | I/II: 55 | – | [48] |
OMVs |
I: 5’-ATA CCA GCT TAT TCA ATT GGG TGA GGG GGG GTT CAC AAC GTT AAA GAT AGA CGG GGG AAG ATA GTA AGT GCA ATC T-3’ II: 5’-ATA CCA GCT TAT TCA ATT CCG AGT CCA GAC TCA CCG CCG CCT CCT CAA GAC GTG CTG GAG ATA GTA AGT GCA ATC T-3’ |
– | Enzyme-linked aptamer assay | DNA | I/II: 76 |
E. coli DH5α: 0.13 ± 0.01 μg/mL E. coli K12: 3.70 ± 0.98 μg/mL S.marcescens: 0.23 ± 0.16 μg/m |
[49] |
P.aeruginosa | apt: 5’-CCC CCG TTG CTT TCG CTT TTC CTT TCG CTT TTG TTC GTT TCG TCC CTG CTT CCT TTC TTG-3’ | – | Vertical capacitance aptasensors | DNA | 60 |
100 CFU/mL Biofilm: 20% of the area |
[46] |
apt: 5’-CCC CCG TTG CTT TCG CTT TTC CTT TCG CTT TTG TTC GTT TCG TCC CTG CTT CCT TTC TTG-3’ | – | Electrical antimicrobial susceptibility test (e-AST) system | DNA | 60 | – | [47] | |
K.pneumoniae | apt: 5’-GCA ATG GTA CGG TAC TTC C(N45)-CAA AAG TGC ACG CTA CTT TGC TAA-3’ | – | Electrical antimicrobial susceptibility test (e-AST) system | DNA | 44 | – | [47] |
E. faecalis | apt: 5’-ATC CAG AGT GAC GCA GCA CGA CAC GTT AGG TTG GTT AGG TTG GTT AGT TTC TTG TGG ACA CGG TGG CTT A-3’ | – | Electrical antimicrobial susceptibility test (e-AST) system | DNA | 70 | – | [47] |
LPS | apt: 5’ -CTT CTG CCC GCC TCC TTC C-(45 N)-GGA GAC GAG ATA GGC GGA CAC T-3’ | Gold disk electrodes | Electrochemical | DNA | 86 | 0.01–1 ng/mL | [50] |
Gra AuNPs |
Electrochemical |
8.7 fg/mL 10–50 fg/mL |
[51] | ||||
Gold atomic cluster | Electrochemical | 7.94 × 10–21 M and 0.01aM–1 pM | [52] | ||||
RGO/AuNPs | Electrochemical | 1 fg/mL | [53] | ||||
RGO/AuNPs | Electrochemical | 0.2 fg/mLand 0.001–0.01 pg/mL | [54] | ||||
MoS2 AuNPs RGO | Voltammetric biosensor | 3.01 × 10–5 ng/mL and 5.0 × 10−5 ng/mL to 2.0 × 10–2 ng/mL | [55] | ||||
– | Optical sensor | 5.5 pg/mL– 100 ng/mL | [56] | ||||
SLG | Acoustic wave biosensor |
3.53 ng/mL 0–100 ng/mL |
[57] | ||||
GO | Fluorescence quenching efficiency |
15.7 ng/mL and 25–1600 ng/mL |
[58] | ||||
RGO |
Fluorescence quenching efficiency Continuous Injection-Electrostacking |
8.3 fM | [59] | ||||
IL-6 |
Model number: ATW0082 ATW0077 |
AuNPs | Optical approach | – | – | 1.95 μg/mL | [60] |
apt: 5′-GTC TCT GTG TGC GCC AGA GAC ACT GGG GCA GAT ATG GGC CAG CAC AGA ATG AGG CCC-3′ | AuNPs | Electrochemical | – | – | 1.6 pg/ml | [61] | |
Model number: ATW0077 | Carbon nanotube | Microfluidic-based approach | – | – | 1 pg/mL–10 ng/mL | [62] | |
apt: 5’- GGT GGC AGG AGG ACT ATT TAT TTG CTT TTC T -3’ | GR | Field-Effect Transistor-Based Approach | – | – | 139 fM | [63] | |
– | GR | Field-Effect Transistor-Based Approach | – | – | 618 fM | [64] | |
CRP | apt: 5’-GGC AGG AAG ACA AAC ACG ATG GGG GGG TAT GAT TTG ATG TGG TTG TTG CAT GAT CGT GGT CTG TGG TGC TGT-3’ | – | Optical fiber sensor | DNA | 72 | 2–20 mg/mL | [65] |
apt: 5’-GCC UGU AAG GUG GUC GGU GUG GCG AGU GUG UUA GGA GAG AUU GC-3’ | – | Luminex xMAP technology | RNA | 44 | 0.4 mg/L | [66] | |
apt: 5’-CGA AGG GGA TTC GAG GGG TGA TTG CGT GCT CCA TTT GGT G- 3’ | AuNPs | Optical nanosensor | DNA | 40 | 1.77 pM | [67] |